Earnings Call · Q1 FY2023·2023-05-03

Q1 23EPS +36.84%·Rev n/aQ4 22EPS 0.00%·Rev n/aQ3 22EPS +4.17%·Rev n/aQ2 22EPS -2.86%·Rev n/a⚠ consensus missing

Aquestive Therapeutics, Inc. AQST

Bennett Watson

Dan Barber — Chief Executive Officer

Ernie Toth — Chief Financial Officer

+20.9%1d on move date+21.5% vs SPY3d+46.8%5d+67.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AQST calls or request research access.

More AQST calls Browse calls Request research access